Related Experiment Videos
Renal therapy using tissue-engineered constructs and gene delivery
1Department of Urology, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
Currently available renal replacement therapies are not optimal for most patients. In addition to the inherent shortage of transplant organs, significant complications are associated with renal transplantation and immunosuppressive therapy. Dialysis neglects the resorptive, homeostatic, metabolic, and endocrinologic functions of the kidney and only partially replaces its filtration properties, resulting in morbidity and mortality. Application of tissue-engineering techniques may improve many aspects of renal function replacement. Identification of the growth factors capable of directing tissue development and of the technique to be used for their delivery would aid in the engineering of human tissue. The combination of tissue-engineering strategies with gene therapy might allow the transfection of diseased tissues with designated cDNA to eliminate inherent or acquired defects. Devices that have been targeted at replacing a single aspect of renal function, in addition to three-dimensional renal units that are capable of excreting urine-like solutes, have been used experimentally. Combination of these strategies may allow the formation of tissue-engineered kidneys in the future.
Insights
Tissue engineering and gene therapy offer promising solutions to improve kidney function replacement. Future strategies aim to engineer functional kidneys, overcoming limitations of current renal replacement therapies.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Nephrology
Background:
- Current renal replacement therapies, including dialysis and transplantation, have significant limitations and complications.
- Dialysis fails to replicate the kidney's complex metabolic, homeostatic, and endocrine functions.
- Renal transplantation faces organ shortages and requires lifelong immunosuppression.
Purpose of the Study:
- To explore the potential of tissue-engineering techniques for improved renal function replacement.
- To investigate the role of growth factors and delivery methods in engineering kidney tissue.
- To assess the combination of tissue engineering with gene therapy for correcting renal defects.
Main Methods:
- Review of current tissue-engineering strategies for renal function replacement.
- Identification of key growth factors and delivery systems for tissue development.
- Exploration of gene therapy approaches for correcting kidney disease.
- Analysis of experimental devices and three-dimensional renal units.
Main Results:
- Tissue engineering holds promise for addressing multiple aspects of renal function.
- Growth factors and targeted delivery are crucial for engineered tissue development.
- Gene therapy combined with tissue engineering may correct inherent or acquired renal defects.
- Experimental devices and renal units show potential for partial renal function replacement.
Conclusions:
- Tissue engineering, potentially combined with gene therapy, offers a future path toward engineered kidneys.
- These advanced strategies may overcome the limitations of current renal replacement therapies.
- Further research into growth factors, delivery systems, and integrated approaches is warranted.